Shtroblia V, Petakh P, Kamyshna I, Halabitska I, Kamyshnyi O
Front Med (Lausanne). 2025; 12:1523027.
PMID: 39906596
PMC: 11790583.
DOI: 10.3389/fmed.2025.1523027.
Song X, Liu Y, Chen S, Zhang L, Zhang H, Shen X
Animal Model Exp Med. 2024; 7(2):114-126.
PMID: 38409942
PMC: 11079151.
DOI: 10.1002/ame2.12389.
Reina-Mahecha A, Beers M, van der Veen H, Zuhorn I, van Kooten T, Sharma P
Tissue Eng Regen Med. 2023; 20(7):1041-1052.
PMID: 37861960
PMC: 10645985.
DOI: 10.1007/s13770-023-00573-6.
Chang L, Wu S, Chen C, Chen J, Huang W, Wu C
Int J Mol Sci. 2023; 24(17).
PMID: 37686220
PMC: 10487932.
DOI: 10.3390/ijms241713414.
Warren M, Bajpayee A
Bioelectricity. 2023; 4(4):248-258.
PMID: 36644714
PMC: 9811830.
DOI: 10.1089/bioe.2021.0026.
Effects of polycationic drug carriers on the electromechanical and swelling properties of cartilage.
Warren M, Vedadghavami A, Bhagavatula S, Bajpayee A
Biophys J. 2022; 121(18):3542-3561.
PMID: 35765244
PMC: 9515003.
DOI: 10.1016/j.bpj.2022.06.024.
Mouse Models of Osteoarthritis: A Summary of Models and Outcomes Assessment.
Drevet S, Favier B, Brun E, Gavazzi G, Lardy B
Comp Med. 2022; 72(1):3-13.
PMID: 34986927
PMC: 8915410.
DOI: 10.30802/AALAS-CM-21-000043.
EANM recommendations based on systematic analysis of small animal radionuclide imaging in inflammatory musculoskeletal diseases.
Aarntzen E, Noriega-Alvarez E, Artiko V, Dias A, Gheysens O, Glaudemans A
EJNMMI Res. 2021; 11(1):85.
PMID: 34487263
PMC: 8421483.
DOI: 10.1186/s13550-021-00820-8.
PHB/CHIT Scaffold as a Promising Biopolymer in the Treatment of Osteochondral Defects-An Experimental Animal Study.
Petrovova E, Tomco M, Holovska K, Danko J, Kresakova L, Vdoviakova K
Polymers (Basel). 2021; 13(8).
PMID: 33920328
PMC: 8069702.
DOI: 10.3390/polym13081232.
Periostin loss-of-function protects mice from post-traumatic and age-related osteoarthritis.
Attur M, Duan X, Cai L, Han T, Zhang W, Tycksen E
Arthritis Res Ther. 2021; 23(1):104.
PMID: 33832532
PMC: 8028178.
DOI: 10.1186/s13075-021-02477-z.
Current Models for Development of Disease-Modifying Osteoarthritis Drugs.
Makarczyk M, Gao Q, He Y, Li Z, Gold M, Hochberg M
Tissue Eng Part C Methods. 2021; 27(2):124-138.
PMID: 33403944
PMC: 8098772.
DOI: 10.1089/ten.TEC.2020.0309.
Effects of miR-146a-5p on chondrocyte interleukin-1-induced inflammation and apoptosis involving thioredoxin interacting protein regulation.
Zhao G, Gu W
J Int Med Res. 2020; 48(11):300060520969550.
PMID: 33161770
PMC: 7658527.
DOI: 10.1177/0300060520969550.
Understanding cartilage protection in OA and injury: a spectrum of possibilities.
Masson A, Krawetz R
BMC Musculoskelet Disord. 2020; 21(1):432.
PMID: 32620156
PMC: 7334861.
DOI: 10.1186/s12891-020-03363-6.
Genetic correlations between cartilage regeneration and degeneration reveal an inverse relationship.
Rai M, Cheverud J, Schmidt E, Sandell L
Osteoarthritis Cartilage. 2020; 28(8):1111-1120.
PMID: 32437968
PMC: 7387169.
DOI: 10.1016/j.joca.2020.04.013.
COMBSecretomics: A pragmatic methodological framework for higher-order drug combination analysis using secretomics.
Chantzi E, Neidlin M, Macheras G, Alexopoulos L, Gustafsson M
PLoS One. 2020; 15(5):e0232989.
PMID: 32407402
PMC: 7224510.
DOI: 10.1371/journal.pone.0232989.
Effects of cartilage-targeting moieties on nanoparticle biodistribution in healthy and osteoarthritic joints.
Brown S, Wang L, Jungels R, Sharma B
Acta Biomater. 2019; 101:469-483.
PMID: 31586725
PMC: 7025912.
DOI: 10.1016/j.actbio.2019.10.003.
The genetic relationship of SOX9 polymorphisms with osteoarthritis risk in Chinese population: A case-control study.
Wang Y, Zhang X, Niu X, Xu Y, Lu L, Li H
Medicine (Baltimore). 2019; 98(8):e14096.
PMID: 30813126
PMC: 6408012.
DOI: 10.1097/MD.0000000000014096.
Diagnostic utility of fluorogenic peptide-conjugated Au nanoparticle probe corroborated by rabbit model of mild cartilage injury and panel of osteoarthritic patients.
Liu Z, Hu X, Yang P, Zhang J, Zhou C, Ao Y
Am J Transl Res. 2018; 10(8):2277-2289.
PMID: 30210670
PMC: 6129508.